COMMUNIQUÉS West-GlobeNewswire

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas
01/02/2018
Data Demonstrate AFM13 in Combination with Keytruda® (Pembrolizumab) Doubled Complete Response Rate in Hodgkin Lymphoma Patients Early Data Suggest New Opportunity for AFM13 in CD30-positive Lymphoma AFM13 is Clinically [...]
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
01/02/2018
2017 revenue of $159.2 million, an increase of 96 percent from 2016 Fourth quarter revenue of $53.3 million, an increase of 124 percent from fourth quarter 2016 Cash and marketable securities at December 31, 2017 of $ [...]
Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening
01/02/2018
BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than 1000 people screened [...]
Assure Holdings to Present at the 2018 World Outlook Financial Conference
01/02/2018
PARKER, Colo., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, will be participating in the 2018 [...]
Devonian Announces Acquisition of Altius Healthcare
01/02/2018
Transaction highlights: Provide Devonian sales and marketing bench strength Create a compelling financial and operational platform for future growth QUÉBEC CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group [...]
Devonian annonce l’acquisition de Altius Healthcare
01/02/2018
Faits saillants de la transaction: Procure des capacités de vente et de marketing à Devonian Création d’une plate-forme opérationnelle et financière probante pour la croissance future QUÉBEC, 01 févr. 2018 (GLOBE [...]
Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhibitor at 10th Annual T-Cell Lymphoma Forum
01/02/2018
BURLINGAME, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Diffusion Pharmaceuticals Announces Allowances of Two U.S. Patent Applications
01/02/2018
CHARLOTTESVILLE, Va., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies
01/02/2018
GAITHERSBURG, Md., Feb. 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it has introduced a Research Use Only (RUO) Acuitas® AMR Gene Panel u5.47 test for commercial sale. The Acuitas AMR [...]
Shire plc : Total voting rights
01/02/2018
Total Voting Rights February 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
Celtaxsys announces the issue of four new patents expanding its pipeline of selective leukotriene B4 modulation anti-inflammatory medicines
01/02/2018
New patents build on previously granted composition of matter protection for acebilustat, with additional intellectual protection for use in cystic fibrosis, as well as new compositions for second generation anti- [...]
Vericel to Present at the 7th Annual Leerink Partners Global Healthcare Conference
01/02/2018
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Spero Announces Appointment of David P. Southwell to its Board of Directors
01/02/2018
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]
Spectral Medical Announces the Appointment of Chief Financial Officer
01/02/2018
TORONTO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Richard Wieland II has been [...]
Delcath Announces Satisfaction of 2016 Convertible Note
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has satisfied all of [...]
Evolve BioSystems Partners With King’s College London to Resolve Gut Dysbiosis in C-Section Delivered Infants
01/02/2018
DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a leader in advancing infant nutrition and health through restoration of the gut microbiome, announced today a collaboration with King’s College [...]
First Patient Enrolled in AlloSure Registry
01/02/2018
BRISBANE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Invuity to Present at Leerink Global Healthcare Conference
01/02/2018
SAN FRANCISCO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at [...]
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
01/02/2018
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from [...]

Pages